Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes - Concepedia

Concepedia

Publication | Closed Access

Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes

25

Citations

0

References

2013

Year

Ergün Bozoğlu, Umut Safer, Aydoğan Aydoğdu, Başak Yılmaz, Hüseyin Doruk

Endocrine Metabolic & Immune Disorders - Drug Targets

Abstract

In this pilot study, addition of vildagliptin to ongoing metformin therapy in elderly with diabetes was accompanied by stable cognitive and functional performance after almost one year of follow-up.